Search for Clinical Trial Results

Sponsored By

Sideroblastic Anemia Pyridoxine-refractory Autosomal Recessive - 7 Studies Found

Status Study
Completed Study Name: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Myeloid Leukemia With 11q23 (MLL)
    Date: 2001-03-03
    Interventions:
    • Drug: bryostatin 1 Given IV
Active, not recruiting Study Name: Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Condition:
  • Adult Acute Myeloid Leukemia in Remission
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abno
    Date: 2001-01-06
    Interventions:
    • Radiation: iodine I 131 monoclonal antibody BC8

Completed Study Name: Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Date: 1999-11-01
Interventions: Drug: amifostine trihydrate
Completed Study Name: Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Date: 2001-08-10
Interventions: Drug: gemtuzumab ozogamicin
Completed Study Name: Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Date: 2007-08-06
Interventions:
  • Biological: PR1 leukemia peptide vaccine
  • B
Completed Study Name: Infliximab in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Date: 2003-12-10
Interventions: Biological: infliximab
Completed Study Name: Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
Condition:
  • Leukemia
  • Myelodysplastic Syndromes

Date: 2001-09-13
Interventions:
  • Drug: busulfan
  • Drug: cyclophosphamide